Canine p-tau202 and 205 antibody and antigen (recombinant protein)
Diagnostic anti-Canine p-tau202 and 205 antibodies pairs and antigen for animal health (animal Dog/Canine Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-p-tau202-205-Ag01 | Canine p-tau202 and 205 | $3090.00 |
GMP-CAN-p-tau202-205-Ab01 | Anti-Canine p-tau202 and 205 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-p-tau202-205-Ab02 | Anti-Canine p-tau202 and 205 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-p-tau202-205-Ab03 | Anti-Canine p-tau202 and 205 human monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-p-tau202-205-Ab04 | Anti-Canine p-tau202 and 205 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-CAN-p-tau202-205-Ag01 |
Product Name | Canine p-tau202 and 205 |
Target/Biomarker | Canine p-tau202 and 205 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine p-tau202 and 205 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau202 and 205 level test of animal Dog/Canine with Alzheimer Disease(AD). |
Tag | His | Reconized/Reactive Specics | Canine p-tau202 and 205 |
Product description | Recombinant Canine p-tau202 and 205 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-p-tau202-205-Ab01,GMP-CAN-p-tau202-205-Ab02 |
Target/Biomarker | Canine p-tau202 and 205 |
Product Name | Anti-Canine p-tau202 and 205 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine p-tau202 and 205 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine p-tau202 and 205 antibodies in Canine p-tau202 and 205 level test of animal Dog/Canine with Alzheimer Disease(AD). |
Product description | Anti-Canine p-tau202 and 205 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine p-tau202 and 205 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-p-tau202-205-Ab03,GMP-CAN-p-tau202-205-Ab04 |
Target/Biomarker | Canine p-tau202 and 205 |
Product Name | Anti-Canine p-tau202 and 205 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Canine p-tau202 and 205 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine p-tau202 and 205 antibodies in Canine p-tau202 and 205 level test of animal Dog/Canine with Alzheimer Disease(AD). |
Product description | Anti-Canine p-tau202 and 205 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Canine p-tau202 and p-tau205, the phosphorylated Tau Protein 202 and 205 variants specific to dogs, represent pivotal players in the intricate landscape of canine neurobiology. At their core, they are Tau proteins that have undergone precise biochemical modifications – phosphorylation – at residues 202 and 205, respectively. Tau proteins, in their unmodified form, are essential for maintaining microtubule stability within neuronal cells, ensuring proper axonal structure and intracellular transport.
However, the story takes a dramatic turn in the context of neurodegenerative diseases. Phosphorylation events can trigger Tau proteins' misfolding and aggregation, leading to the formation of neurofibrillary tangles. Canine p-tau202 and p-tau205 are particularly prone to this transformation. These tangles are pathological signatures of several neurodegenerative conditions in dogs, contributing to progressive neuronal dysfunction, synaptic disruption, and cognitive impairment.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.